ATE317020T1 - Neues regulationssystem zur kontrolle der expression eines transgens - Google Patents
Neues regulationssystem zur kontrolle der expression eines transgensInfo
- Publication number
- ATE317020T1 ATE317020T1 AT99971861T AT99971861T ATE317020T1 AT E317020 T1 ATE317020 T1 AT E317020T1 AT 99971861 T AT99971861 T AT 99971861T AT 99971861 T AT99971861 T AT 99971861T AT E317020 T1 ATE317020 T1 AT E317020T1
- Authority
- AT
- Austria
- Prior art keywords
- controlling
- expression
- nucleic acid
- transgene
- regulatory system
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Psychology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Mushroom Cultivation (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Video Image Reproduction Devices For Color Tv Systems (AREA)
- Circuit Arrangement For Electric Light Sources In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9814080A FR2786198B1 (fr) | 1998-11-09 | 1998-11-09 | Nouveau systeme de regulation de l'expression d'un transgene |
US12260099P | 1999-03-03 | 1999-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE317020T1 true ATE317020T1 (de) | 2006-02-15 |
Family
ID=26234639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99971861T ATE317020T1 (de) | 1998-11-09 | 1999-11-09 | Neues regulationssystem zur kontrolle der expression eines transgens |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1129204B1 (de) |
JP (1) | JP4516215B2 (de) |
KR (1) | KR20020013476A (de) |
CN (1) | CN1352694A (de) |
AT (1) | ATE317020T1 (de) |
AU (1) | AU1165400A (de) |
CA (1) | CA2351015C (de) |
DE (1) | DE69929718T2 (de) |
HU (1) | HUP0104032A3 (de) |
IL (1) | IL142761A0 (de) |
WO (1) | WO2000028062A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440741B2 (en) * | 1999-03-15 | 2002-08-27 | The Trustees Of Columbia University In The City Of New York | Expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
WO2002086131A1 (fr) * | 2001-04-09 | 2002-10-31 | Gencom Corporation | Unite de regulation de l'expression genetique et utilisation de cette unite |
CN1453361A (zh) * | 2003-05-30 | 2003-11-05 | 中国科学院上海生命科学研究院 | 一种抗癌靶向可调控基因-病毒的构建方法 |
AU2010316996A1 (en) * | 2009-11-05 | 2012-06-14 | Proyecto De Biomedicina Cima, S.L. | Regulated expression systems |
CN102690338A (zh) * | 2012-05-25 | 2012-09-26 | 中国农业大学 | 一种与四环素结合的蛋白TetR及其编码基因和应用 |
CN110358812B (zh) * | 2019-06-25 | 2022-12-27 | 武汉生物工程学院 | 一种用于λ-Red重组系统基因敲除重组阳性克隆检测的引物及检测方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994029442A2 (en) * | 1993-06-14 | 1994-12-22 | Basf Aktiengesellschaft | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
US5965440A (en) * | 1995-12-07 | 1999-10-12 | The General Hospital Corporation | Controlled gene product delivery from a regulatable retroviral vector |
WO1998037185A2 (en) * | 1997-02-20 | 1998-08-27 | The Board Of Regents Of The University Of Texas System | Vectors for controlled gene expression |
-
1999
- 1999-11-09 HU HU0104032A patent/HUP0104032A3/hu unknown
- 1999-11-09 AT AT99971861T patent/ATE317020T1/de not_active IP Right Cessation
- 1999-11-09 DE DE69929718T patent/DE69929718T2/de not_active Expired - Lifetime
- 1999-11-09 EP EP99971861A patent/EP1129204B1/de not_active Expired - Lifetime
- 1999-11-09 IL IL14276199A patent/IL142761A0/xx unknown
- 1999-11-09 WO PCT/FR1999/002752 patent/WO2000028062A1/fr active IP Right Grant
- 1999-11-09 CN CN99813858A patent/CN1352694A/zh active Pending
- 1999-11-09 JP JP2000581228A patent/JP4516215B2/ja not_active Expired - Fee Related
- 1999-11-09 AU AU11654/00A patent/AU1165400A/en not_active Abandoned
- 1999-11-09 KR KR1020017005743A patent/KR20020013476A/ko not_active Application Discontinuation
- 1999-11-09 CA CA2351015A patent/CA2351015C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2351015A1 (fr) | 2000-05-18 |
JP2002529099A (ja) | 2002-09-10 |
DE69929718T2 (de) | 2006-11-09 |
JP4516215B2 (ja) | 2010-08-04 |
CN1352694A (zh) | 2002-06-05 |
KR20020013476A (ko) | 2002-02-20 |
EP1129204A1 (de) | 2001-09-05 |
DE69929718D1 (de) | 2006-04-13 |
WO2000028062A1 (fr) | 2000-05-18 |
IL142761A0 (en) | 2002-03-10 |
HUP0104032A2 (hu) | 2002-02-28 |
AU1165400A (en) | 2000-05-29 |
EP1129204B1 (de) | 2006-02-01 |
CA2351015C (fr) | 2011-09-27 |
HUP0104032A3 (en) | 2003-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69333731D1 (de) | Glialmitogene faktoren, ihre herstellung und verwendung | |
MX9800419A (es) | Haloperoxidasas de curvularia verruculosa y acidos nucleicos que codifican para los mismos. | |
ATE312190T1 (de) | Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung | |
MY125594A (en) | Immortalized cell lines for virus growth | |
DE69834267D1 (de) | Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen | |
DE69635609D1 (de) | Nukleinsäure enthaltende zusammensetzung, herstellung und verwendung | |
ATE355370T1 (de) | Starker homologer promotor aus hamster | |
SG141233A1 (en) | Control of gene expression | |
IL127897A (en) | Hamster ef-1alpha transcriptional regulatory dna | |
DE69333931D1 (de) | Verwendung von Krillenzymen zur Behandlung von Zahnbelag | |
PT851926E (pt) | Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada | |
DE59712094D1 (de) | Mittel zur herstellung von aquarien- und gartenteichwasser und verwendung davon | |
DE60040497D1 (de) | Gene, welche für Flavon-Synthasen kodieren | |
ATE317020T1 (de) | Neues regulationssystem zur kontrolle der expression eines transgens | |
WO2000030667A3 (en) | Compositions and methods using lactadherin or variants thereof | |
HK1038572A1 (en) | Growth differentiation factor promoter and uses therefor | |
WO1999023216A3 (en) | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | |
AU1896500A (en) | High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site | |
AU1054699A (en) | Cold-inducible expression vector | |
AUPM772494A0 (en) | Improvements in production of proteins in host cells | |
WO2003070878A3 (en) | Antisense modulation of hematopoietic cell protein tyrosine kinase expression | |
ATE225852T1 (de) | Menschlicher epidermaler gen-promotor | |
DE50010015D1 (de) | Tetrahydropyrimidin-dioxygenase-gen, dadurch kodierte polypeptide und verfahren zur deren herstellung | |
AU6722498A (en) | Disubstituted biphenyloxazolines | |
ES2164907T3 (es) | Secuencias reguladoras del gen cd4 y su expresion especifica en los linfocitos t maduros. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |